{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:05:52Z","timestamp":1779311152214,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272736,82160467,81460460,81760542"],"award-info":[{"award-number":["82272736,82160467,81460460,81760542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202940"],"award-info":[{"award-number":["82202940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Foundation of the Science and Technology Department of Guangxi Province, China","award":["2023GXNSFDA026009\uff0c2016GXNSFAA380252, 2018AB61001 and 2014GXNSFBA118114"],"award-info":[{"award-number":["2023GXNSFDA026009\uff0c2016GXNSFAA380252, 2018AB61001 and 2014GXNSFBA118114"]}]},{"name":"the Research Foundation of the Health Department of Guangxi Province, China","award":["S2018087"],"award-info":[{"award-number":["S2018087"]}]},{"name":"Guangxi Medical University Training Program for Distinguished Young Scholars","award":["2017"],"award-info":[{"award-number":["2017"]}]},{"name":"Medical Excellence Award Funded by the Creative Research Development Grant from the First Affiliated Hospital of Guangxi Medical University","award":["2016"],"award-info":[{"award-number":["2016"]}]},{"name":"Guangxi Medical High-level Talents Training Program. The central government guide local science and technology development projects","award":["ZY18057006"],"award-info":[{"award-number":["ZY18057006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02301-3","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T03:15:12Z","timestamp":1737947712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma"],"prefix":"10.1186","volume":"30","author":[{"given":"Lanhua","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"1","key":"2301_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2301_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2301_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60\u201372.","journal-title":"N Engl J Med"},{"issue":"9","key":"2301_CR4","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/hed.24687","volume":"39","author":"F Duprez","year":"2017","unstructured":"Duprez F, Berwouts D, De Neve W, Bonte K, Boterberg T, Deron P, et al. Distant metastases in head and neck cancer. Head Neck. 2017;39(9):1733\u201343.","journal-title":"Head Neck"},{"issue":"3","key":"2301_CR5","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3390\/ijms24032782","volume":"24","author":"B Gurbi","year":"2023","unstructured":"Gurbi B, Brauswetter D, P\u00e9nzes K, Varga A, Kren\u00e1cs T, D\u00e1nos K, et al. MEK is a potential indirect target in subtypes of head and neck cancers. Int J Mol Sci. 2023;24(3):2782.","journal-title":"Int J Mol Sci"},{"key":"2301_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.acr.2021.05.002","volume":"152","author":"GR Bhat","year":"2021","unstructured":"Bhat GR, Hyole RG, Li J. Head and neck cancer: current challenges and future perspectives. Adv Cancer Res. 2021;152:67\u2013102.","journal-title":"Adv Cancer Res"},{"issue":"6","key":"2301_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/biomedicines9060694","volume":"9","author":"YCE Wan","year":"2021","unstructured":"Wan YCE, Chan KM. Histone H2B mutations in cancer. Biomedicines. 2021;9(6):694.","journal-title":"Biomedicines"},{"issue":"3","key":"2301_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.313","volume":"11","author":"X Chai","year":"2021","unstructured":"Chai X, Guo J, Dong R, Yang X, Deng C, Wei C, et al. Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma. Clin Transl Med. 2021;11(3): e313.","journal-title":"Clin Transl Med"},{"key":"2301_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.916568","volume":"13","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhao X, Wang R, Tang X, Zhao Y, Zhong G, et al. Heterogeneous pattern of gene expression driven by TTN mutation is involved in the construction of a prognosis model of lung squamous cell carcinoma. Front Oncol. 2023;13: 916568.","journal-title":"Front Oncol"},{"key":"2301_CR10","first-page":"7593787","volume":"2016","author":"Y Wu","year":"2016","unstructured":"Wu Y, Gu Y, Guo S, Dai Q, Zhang W. Expressing status and correlation of ARID1A and histone H2B on breast cancer. Biomed Res Int. 2016;2016:7593787.","journal-title":"Biomed Res Int"},{"key":"2301_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.966817","volume":"12","author":"J Jia","year":"2022","unstructured":"Jia J, Han Z, Wang X, Zheng X, Wang S, Cui Y. H2B gene family: a prognostic biomarker and correlates with immune infiltration in glioma. Front Oncol. 2022;12: 966817.","journal-title":"Front Oncol"},{"issue":"2","key":"2301_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/gcc.22802","volume":"59","author":"JQ Wang","year":"2020","unstructured":"Wang JQ, Yan FQ, Wang LH, Yin WJ, Chang TY, Liu JP, et al. Identification of new hypoxia-regulated epithelial-mesenchymal transition marker genes labeled by H3K4 acetylation. Genes Chromosom Cancer. 2020;59(2):73\u201383.","journal-title":"Genes Chromosom Cancer"},{"issue":"5","key":"2301_CR13","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.3390\/ijms22052778","volume":"22","author":"M Markouli","year":"2021","unstructured":"Markouli M, Strepkos D, Basdra EK, Papavassiliou AG, Piperi C. Prominent role of histone modifications in the regulation of tumor metastasis. Int J Mol Sci. 2021;22(5):2778.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2301_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"4","key":"2301_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00011-023-01710-6","volume":"72","author":"J Sim","year":"2023","unstructured":"Sim J, Ahn JW, Park J, Kim YJ, Jeong JY, Lee JM, et al. Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy. Inflamm Res. 2023;72(4):813\u201327.","journal-title":"Inflamm Res"},{"issue":"23","key":"2301_CR16","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1080\/15384101.2015.1104437","volume":"14","author":"A Estrada-Bernal","year":"2015","unstructured":"Estrada-Bernal A, Chatterjee M, Haque SJ, Yang L, Morgan MA, Kotian S, et al. MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways. Cell Cycle. 2015;14(23):3713\u201324.","journal-title":"Cell Cycle"},{"issue":"1","key":"2301_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2301_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2301_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"2301_CR20","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.3390\/cancers13205206","volume":"13","author":"SF Powell","year":"2021","unstructured":"Powell SF, Vu L, Spanos WC, Pyeon D. The key differences between human papillomavirus-positive and -negative head and neck cancers: biological and clinical implications. Cancers. 2021;13(20):5206.","journal-title":"Cancers"},{"issue":"1","key":"2301_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15(1):44.","journal-title":"Int J Oral Sci"},{"issue":"7749","key":"2301_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-019-1038-1","volume":"567","author":"BA Nacev","year":"2019","unstructured":"Nacev BA, Feng L, Bagert JD, Lemiesz AE, Gao J, Soshnev AA, et al. The expanding landscape of \u2018oncohistone\u2019 mutations in human cancers. Nature. 2019;567(7749):473\u20138.","journal-title":"Nature"},{"key":"2301_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.canlet.2017.03.007","volume":"396","author":"FL Monteiro","year":"2017","unstructured":"Monteiro FL, Vitorino R, Wang J, Cardoso H, Laranjeira H, Sim\u00f5es J, et al. The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial-mesenchymal transition in mammary epithelial and in breast cancer cells. Cancer Lett. 2017;396:42\u201352.","journal-title":"Cancer Lett"},{"issue":"1","key":"2301_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13072-017-0155-z","volume":"10","author":"S Bhattacharya","year":"2017","unstructured":"Bhattacharya S, Reddy D, Jani V, Gadewal N, Shah S, Reddy R, et al. Histone isoform H2A1H promotes attainment of distinct physiological states by altering chromatin dynamics. Epigenetics Chromatin. 2017;10(1):48.","journal-title":"Epigenetics Chromatin"},{"issue":"1","key":"2301_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell"},{"issue":"8","key":"2301_CR26","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/ijms21082921","volume":"21","author":"M Oshi","year":"2020","unstructured":"Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Matsuyama R, et al. G2M cell cycle pathway score as a prognostic biomarker of metastasis in estrogen receptor (ER)-positive breast cancer. Int J Mol Sci. 2020;21(8):2921.","journal-title":"Int J Mol Sci"},{"key":"2301_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-4598-8-8","volume":"8","author":"Y Wang","year":"2009","unstructured":"Wang Y, Ji P, Liu J, Broaddus RR, Xue F, Zhang W. Centrosome-associated regulators of the G(2)\/M checkpoint as targets for cancer therapy. Mol Cancer. 2009;8:8.","journal-title":"Mol Cancer"},{"issue":"2","key":"2301_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/cancers12020306","volume":"12","author":"AY Deneka","year":"2020","unstructured":"Deneka AY, Einarson MB, Bennett J, Nikonova AS, Elmekawy M, Zhou Y, et al. Synthetic lethal targeting of mitotic checkpoints in HPV-negative head and neck cancer. Cancers. 2020;12(2):306.","journal-title":"Cancers"},{"key":"2301_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683688","volume":"11","author":"K Hintelmann","year":"2021","unstructured":"Hintelmann K, Berenz T, Kriegs M, Christiansen S, Gatzemeier F, Struve N, et al. Dual inhibition of PARP and the intra-S\/G2 cell cycle checkpoints results in highly effective radiosensitization of HPV-positive HNSCC cells. Front Oncol. 2021;11: 683688.","journal-title":"Front Oncol"},{"issue":"7","key":"2301_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41389-019-0147-x","volume":"8","author":"AM van Harten","year":"2019","unstructured":"van Harten AM, Buijze M, van der Mast R, Rooimans MA, Martens-de Kemp SR, Bachas C, et al. Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death. Oncogenesis. 2019;8(7):38.","journal-title":"Oncogenesis"},{"issue":"1","key":"2301_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/ijms22010240","volume":"22","author":"N Kitamura","year":"2020","unstructured":"Kitamura N, Sento S, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T. Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. Int J Mol Sci. 2020;22(1):240.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2301_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, et al. NCCN Guidelines\u00ae insights: head and neck cancers, version 1.2022. J Natl Compr Cancer Netw. 2022;20(3):224\u201334.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"18","key":"2301_CR33","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA. How taxol\/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25(18):2677\u201381.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"2301_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/00000421-199810000-00013","volume":"21","author":"AD Colevas","year":"1998","unstructured":"Colevas AD, Posner MR. Docetaxel in head and neck cancer: a review. Am J Clin Oncol. 1998;21(5):482\u20136.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2301_CR35","first-page":"1605","volume":"44","author":"M Ren","year":"2020","unstructured":"Ren M, Zhou X, Gu M, Jiao W, Yu M, Wang Y, et al. Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress-mediated apoptosis and G2\/M phase arrest. Oncol Rep. 2020;44(4):1605\u201315.","journal-title":"Oncol Rep"},{"issue":"15","key":"2301_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4161\/cbt.8.15.9081","volume":"8","author":"K Kuntz","year":"2009","unstructured":"Kuntz K, O\u2019Connell MJ. The G(2) DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer? Cancer Biol Ther. 2009;8(15):1433\u20139.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"2301_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5(1):60.","journal-title":"Signal Transduct Target Ther"},{"key":"2301_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107450","volume":"207","author":"A Bradbury","year":"2020","unstructured":"Bradbury A, Hall S, Curtin N, Drew Y. Targeting ATR as cancer therapy: a new era for synthetic lethality and synergistic combinations? Pharmacol Ther. 2020;207: 107450.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"2301_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A Mar\u00e9chal","year":"2013","unstructured":"Mar\u00e9chal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5(9): a012716.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"2301_CR40","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.3390\/ijms24119530","volume":"24","author":"H Lee","year":"2023","unstructured":"Lee H, Ha S, Choi S, Do S, Yoon S, Kim YK, et al. Oncogenic impact of TONSL, a homologous recombination repair protein at the replication fork, in cancer stem cells. Int J Mol Sci. 2023;24(11):9530.","journal-title":"Int J Mol Sci"},{"key":"2301_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.654887","volume":"12","author":"B Gao","year":"2021","unstructured":"Gao B, Baudis M. Signatures of discriminative copy number aberrations in 31 cancer subtypes. Front Genet. 2021;12: 654887.","journal-title":"Front Genet"},{"issue":"4","key":"2301_CR42","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/15592294.2018.1465790","volume":"13","author":"C Zhou","year":"2018","unstructured":"Zhou C, Ye M, Ni S, Li Q, Ye D, Li J, et al. DNA methylation biomarkers for head and neck squamous cell carcinoma. Epigenetics. 2018;13(4):398\u2013409.","journal-title":"Epigenetics"},{"key":"2301_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.982241","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhao J, Zhong M, Zhang Q, Yan F, Feng Y, et al. The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma. Front Genet. 2022;13: 982241.","journal-title":"Front Genet"},{"issue":"3","key":"2301_CR44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/mc.22577","volume":"56","author":"K Misawa","year":"2017","unstructured":"Misawa K, Mochizuki D, Endo S, Mima M, Misawa Y, Imai A, et al. Site-specific methylation patterns of the GAL and GALR1\/2 genes in head and neck cancer: potential utility as biomarkers for prognosis. Mol Carcinog. 2017;56(3):1107\u201316.","journal-title":"Mol Carcinog"},{"issue":"6","key":"2301_CR45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0022034518760297","volume":"97","author":"T Fukusumi","year":"2018","unstructured":"Fukusumi T, Califano JA. The NOTCH pathway in head and neck squamous cell carcinoma. J Dent Res. 2018;97(6):645\u201353.","journal-title":"J Dent Res"},{"issue":"4","key":"2301_CR46","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/cancers14041080","volume":"14","author":"B Schmidl","year":"2022","unstructured":"Schmidl B, Siegl M, Boxberg M, St\u00f6gbauer F, Jira D, Winter C, et al. NOTCH1 intracellular domain and the tumor microenvironment as prognostic markers in HNSCC. Cancers. 2022;14(4):1080.","journal-title":"Cancers"},{"issue":"1","key":"2301_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jiang Y, Luo Q, Li L, Jia L. Neddylation: a novel modulator of the tumor microenvironment. Mol Cancer. 2019;18(1):77.","journal-title":"Mol Cancer"},{"issue":"2","key":"2301_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/jop.13508","volume":"53","author":"SZ Deng","year":"2024","unstructured":"Deng SZ, Wu X, Kong L, Cheng B, Dai L. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma. J Oral Pathol Med. 2024;53(2):114\u201323.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"2301_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/cancers13051043","volume":"13","author":"LM Jeusset","year":"2021","unstructured":"Jeusset LM, Guppy BJ, Lichtensztejn Z, McDonald D, McManus KJ. Reduced USP22 expression impairs mitotic removal of H2B monoubiquitination, alters chromatin compaction and induces chromosome instability that may promote oncogenesis. Cancers. 2021;13(5):1043.","journal-title":"Cancers"},{"key":"2301_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2017.09.050","volume":"638","author":"KN Berger","year":"2018","unstructured":"Berger KN, Pu JJ. PD-1 pathway and its clinical application: a 20 year journey after discovery of the complete human PD-1 gene. Gene. 2018;638:20\u20135.","journal-title":"Gene"},{"issue":"6","key":"2301_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154074","volume":"132","author":"T Cao","year":"2022","unstructured":"Cao T, Lu Y, Wang Q, Qin H, Li H, Guo H, et al. A CGA\/EGFR\/GATA2 positive feedback circuit confers chemoresistance in gastric cancer. J Clin Invest. 2022;132(6): e154074.","journal-title":"J Clin Invest"},{"issue":"8","key":"2301_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107522","volume":"300","author":"P Wang","year":"2024","unstructured":"Wang P, Zhou Y, Wang J, Zhou Y, Zhang X, Liu Y, et al. miR-107 reverses the multidrug resistance of gastric cancer by targeting the CGA\/EGFR\/GATA2 positive feedback circuit. J Biol Chem. 2024;300(8): 107522.","journal-title":"J Biol Chem"},{"issue":"9","key":"2301_CR53","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1039\/C6MT00076B","volume":"8","author":"KM Bompiani","year":"2016","unstructured":"Bompiani KM, Tsai CY, Achatz FP, Liebig JK, Howell SB. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity. Metallomics. 2016;8(9):951\u201362.","journal-title":"Metallomics"},{"issue":"10","key":"2301_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18397","volume":"28","author":"G Jiang","year":"2024","unstructured":"Jiang G, Xu S, Mai X, Tu J, Wang L, Wang L, et al. SAP deletion promotes malignant insulinoma progression by inducing CXCL12 secretion from CAFs via the CXCR4\/p38\/ERK signalling pathway. J Cell Mol Med. 2024;28(10): e18397.","journal-title":"J Cell Mol Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02301-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T03:19:15Z","timestamp":1737947955000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02301-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02301-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University and the approval number was 2024-E533-01. This study has been officially sanctioned by the Medical Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, thereby waiving the requirement for informed consent from participants. The study did not involve minors. All experiments were performed in accordance with relevant guidelines and regulations. The study was conducted according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}